FDA approves Novo Nordisk's higher-dose Wegovy injection for weight loss

March 19, 2026 12:05 PM

The U.S. Food and Drug Administration approved Novo Nordisk's (NYSE: NVO) Wegovy HD injection, a 7.2 mg dose of semaglutide ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found